Table 6.
The curative effects of the new compounds III against TMV in vivo.
| Agents | Ningnanmycin | III-1 | III-2 | III-3 | III-4 | III-5 |
| Concentration (mg/L) | 500 | 500 | 50 | 500 | 500 | 500 |
| Inhibition rate (%) | 53.5 | 51.1 | 25.3 | 52.9 | 44.7 | 37.9 |
| Agents | III-6 | III-7 | III-8 | III-9 | III-10 | III-11 |
| Concentration (mg/L) | 500 | 500 | 500 | 500 | 500 | 500 |
| Inhibition rate (%) | 37.4 | 49.8 | 50.4 | 27.1 | 9.30 | 50.4 |
| Agents | III-12 | III-13 | III-14 | III-15 | III-16 | III-17 |
| Concentration (mg/L) | 500 | 500 | 500 | 500 | 500 | 500 |
| Inhibition rate (%) | 22.1 | 23.4 | 36.6 | 40.4 | 54.0 | 42.8 |
| Agents | III-18 | III-19 | III-20 | III-21 | III-22 | III-23 |
| Concentration (mg/L) | 500 | 500 | 500 | 500 | 500 | 500 |
| Inhibition rate (%) | 45.6 | 41.4 | 24.6 | 26.1 | 34.8 | 39.9 |
| Agents | III-24 | III-25 | III-26 | III-27 | III-28 | III-29 |
| Concentration (mg/L) | 500 | 500 | 500 | 500 | 500 | 500 |
| Inhibition rate (%) | 43.2 | 40.0 | 29.9 | 41.0 | 41.8 | 38.9 |
| Agents | III-30 | III-31 | ||||
| Concentration (mg/L) | 500 | 500 | ||||
| Inhibition rate (%) | 44.6 | 55.4 |